Angiotensin II type 1 receptor antagonist prevents electrical remodeling in atrial fibrillation

被引：0
|
作者：
Nakashima, H [1 ]
Kumagai, K [1 ]
Gondo, N [1 ]
Urata, H [1 ]
Ideishi, M [1 ]
Arakawa, K [1 ]
机构：
[1] Fukuoka Univ, Fukuoka 81401, Japan
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
55
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] Gene polymorfism of angiotensin-converting enzyme and angiotensin II type 1 receptor in heart failure patients with atrial fibrillation
    Adela, Sitar-Taut
    Dana, Pop
    Dumitru, Zdrenghea
    Maria, Procopciuc Lucia
    Radu, Rosu
    Adela, Popa
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2010, 18 (02): : 35 - 42
  • [42] Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog
    Miyazaki, M
    Shiota, N
    Sakonjo, H
    Takai, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 1999, 79 (04): : 455 - 460
  • [43] Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes
    Polina, Iuliia
    Jansen, Hailey J.
    Li, Tiesong
    Moghtadaei, Motahareh
    Bohne, Loryn J.
    Liu, Yingjie
    Krishnaswamy, Pooja
    Egom, Emmanuel E.
    Belke, Darrell D.
    Rafferty, Sara A.
    Ezeani, Martin
    Gillis, Anne M.
    Rose, Robert A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (14) : 7990 - 8000
  • [44] Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation
    Goette, Andreas
    Schotten, Ulrich
    EUROPEAN HEART JOURNAL, 2006, 27 (17) : 2034 - 2035
  • [45] Electrical remodeling in human atrial fibrillation
    Lee, Hon-Chi
    CHINESE MEDICAL JOURNAL, 2013, 126 (12) : 2380 - 2383
  • [46] Electrical remodeling in human atrial fibrillation
    Hon-Chi Lee
    中华医学杂志（英文版）, 2013, 126 (12) : 2380 - 2383
  • [47] Effects of angiotensin receptor blockade on atrial remodeling and the "second factor" in a goat model of atrial fibrillation
    Hall, M
    Kirubakaran, S
    Peters, N
    Garratt, C
    HEART, 2006, 92 : A117 - A118
  • [48] Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) TrialRationale and Study Design
    Andreas Goette
    Günter Breithardt
    Thomas Fetsch
    Peter Hanrath
    Helmut U. Klein
    Walter Lehmacher
    Gerhard Steinbeck
    Thomas Meinertz
    Clinical Drug Investigation, 2007, 27 : 697 - 705
  • [49] Angiotensin II antagonist reduces tachycardia-induced electrical remodeling of the atria
    Nakashima, H
    Kumagai, K
    Urata, H
    Gondo, N
    Ideishi, M
    Arakawa, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 98A - 98A
  • [50] Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer
    Miyajima, Akira
    Kikuchi, Eiji
    Kosaka, Takeo
    Oya, Mototsugu
    REVIEWS ON RECENT CLINICAL TRIALS, 2009, 4 (02) : 75 - 78
12345